Context Therapeutics Inc. (CNTX) vs MDxHealth S.A. (MDXH)

A side-by-side comparison of Context Therapeutics Inc. and MDxHealth S.A. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

CNTX

Context Therapeutics Inc.

$31M

$0.33HealthcareDelayed quote: Oct 6, 2026, 10:55 AM EDT

MDXH

MDxHealth S.A.

$31M

$0.60HealthcareDelayed quote: Oct 6, 2026, 10:51 AM EDT

Total return — CNTX vs MDXH

growth of $100 · dividends reinvested · last 5y

CNTX -94.2% (-43.4%/yr)MDXH -95.0% (-45.1%/yr)CNTX compounded faster over this window

CNTX MDXH

CNTX vs MDXH: by the numbers

•MDXH is the larger company ($31M vs $31M market cap).
•Both run net losses; CNTX's is the smaller (0.00% vs -31.07% net margin).

Metrics side by side

Valuation

Metric	CNTX	MDXH
P/B ratio	0.80	N/A

Profitability

Metric	CNTX	MDXH
Gross margin	0.00%	59.74%
Operating margin	0.00%	-14.28%
Net margin	0.00%	-31.07%
ROE	-120.40%	N/A
ROIC	-126.84%	-15.35%

Growth (annualized)

Metric	CNTX	MDXH
Revenue CAGR (5Y)	N/A	42.35%

Go deeper

Full CNTX analysis Full MDXH analysis Interactive comparison tool

Dig into the metrics

Context Therapeutics ROE MDxHealth ROE Context Therapeutics operating margin MDxHealth operating margin Context Therapeutics revenue growth MDxHealth revenue growth Context Therapeutics free cash flow MDxHealth free cash flow

Context Therapeutics & MDxHealth appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.